For children with severe hypertrophic cardiomyopathy caused by gain-of-function RAS/mitogen-activated protein kinase ( ...
As of January 6, 2025, there were six evaluable patients in the Phase 2a arm evaluating IMM-1-104 with modified FOLFIRINOX in ...
News Medical on MSN1h
Genetic discoveries drive new approaches to treating cerebral vascular malformationsCerebral vascular malformations (CVMs), including cerebral arteriovenous malformations (AVMs) and cavernous malformations (CCMs), have long posed challenges due to their complex origins and severe ...
SpringWorks has shown strong revenue growth with OGSIVEO, achieving a 23% increase from Q2 of 2024 to Q3 of 2024. See why I ...
The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback